apollo
logo
0Login
Introducing Our Latest Arrival!
Veprate-ER-250 Tablet 10's

Veprate-ER-250 Tablet 10's

Prescription drug
 Trailing icon
Consult Doctor

Composition

DIVALPROEX-250MG

Manufacturer/Marketer

Ryon Pharma

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-26

for this medicine

About Veprate-ER-250 Tablet

Veprate-ER-250 Tablet is used to treat epilepsy/seizures/fits. Additionally, Veprate-ER-250 Tablet is also used to treat manic episodes associated with bipolar disorder and prevent migraines. Epilepsy is a sudden rush of electricity in the brain. In epilepsy, the brain's electrical rhythms become imbalanced, resulting in recurrent seizures.

Veprate-ER-250 Tablet contains 'Divalproex', which decreases the brain's excessive and abnormal nerve activity. Thereby helping in controlling seizures. Veprate-ER-250 Tablet increases the amount of a chemical substance called GABA; this helps block nerve transmission across the brain and provides a calming effect. Thereby helping treat bipolar disorder. 

Take Veprate-ER-250 Tablet with or without food. Depending on your medical condition, you are advised to take Veprate-ER-250 Tablet for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects, such as abdominal pain, back pain, constipation, diarrhoea, dizziness, nausea, increased appetite, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Please do not stop taking Veprate-ER-250 Tablet without consulting your doctor to avoid worsening seizures. Do not take Veprate-ER-250 Tablet if you are pregnant, as it could cause serious birth defects. If you are of childbearing age, use effective contraception while taking Veprate-ER-250 Tablet . Consult your doctor before taking Veprate-ER-250 Tablet if you are breastfeeding. Avoid driving or operating machinery as Veprate-ER-250 Tablet causes dizziness and may affect thinking and motor skills. Avoid consuming alcohol along with Veprate-ER-250 Tablet as it could lead to increased dizziness. Care should be taken while giving Veprate-ER-250 Tablet to children below two years as there is a higher risk of liver intoxication during the first 6months of treatment. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Uses of Veprate-ER-250 Tablet

Treatment of Epilepsy, bipolar disorder, migraine.

Medicinal Benefits

Veprate-ER-250 Tablet belongs to a group of medicines called anticonvulsants or anti-epileptics. Veprate-ER-250 Tablet is used to treat epilepsy/seizures/fits. Also, Veprate-ER-250 Tablet is used to treat mood disorders and prevent migraine headaches. Veprate-ER-250 Tablet decreases the excessive and abnormal nerve activity in the brain. Thereby helping in controlling seizures. Veprate-ER-250 Tablet treats mood disorders by increasing the amount of a chemical substance called GABA; this helps block nerve transmission across the brain and provides a calming effect. Veprate-ER-250 Tablet prevents migraine headaches by limiting the transmission of nerve pain. Veprate-ER-250 Tablet is used alone or in combination to treat simple, complex partial, and complex absence seizures. Veprate-ER-250 Tablet is used in combination to treat multiple seizures, such as absence seizures.

Directions for Use

Tablet/Capsule: Swallow it as a whole with a glass of water; do not chew or crush it.Syrup/Suspension/Drops: Take the prescribed dose by mouth using the measuring cup/dosing syringe/dropper provided by the pack; shake the pack well before each use.Sprinkle capsule: Swallow it as a whole with water or sprinkle the capsule contents on food and consume.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Veprate-ER-250 Tablet

  • Abdominal pain

  • Back pain

  • Constipation

  • Diarrhoea

  • Dizziness

  • Nausea

  • Increased appetite

  • Vomiting

  • Vision problems

  • Weight changes

  • Problems with walking or coordination

Drug Warnings

Do not take Veprate-ER-250 Tablet if you are allergic to any of its contents, have/ had liver problems or urea cycle disorders. Inform your doctor before taking Veprate-ER-250 Tablet if you have pancreatitis, blood problems or multi-organ hypersensitivity. Consult your doctor immediately if you experience suicidal tendencies while taking Veprate-ER-250 Tablet . Veprate-ER-250 Tablet may cause thrombocytopenia (low blood platelets), hyperammonemia (high levels of ammonia in the blood), hypothermia (low body temperature) and liver problems. Please do not stop taking Veprate-ER-250 Tablet without consulting your doctor to avoid worsening of seizures. Do not take Veprate-ER-250 Tablet if you are pregnant, as it could cause serious birth defects. If you are of childbearing age, use effective contraception while taking Veprate-ER-250 Tablet . Consult your doctor before taking Veprate-ER-250 Tablet if you are breastfeeding. Avoid driving or operating machinery as Veprate-ER-250 Tablet causes dizziness and may affect thinking and motor skills. Avoid consuming alcohol along with Veprate-ER-250 Tablet as it could lead to increased dizziness. Care should be taken while giving Veprate-ER-250 Tablet to children below 2 years as there is a higher risk of liver intoxication during the first six months of treatment.

Drug Interactions

Drug-Drug Interactions: Veprate-ER-250 Tablet may have interaction with pain killers (aspirin), anti-epileptics (pregabalin, topiramate, phenobarbital, primidone, phenytoin, carbamazepine, lamotrigine, felbamate, ethosuximide), anti-HIV (zidovudine), anti-depressant (duloxetine, escitalopram, amitriptyline, nortriptyline), anti-psychotic (aripiprazole, lurasidone, quetiapine), anti-anxiety (alprazolam), anti-TB (rifampicin), anti-coagulant (warfarin), antibiotics (imipenem, meropenem), and benzodiazepine (diazepam).

Drug-Food Interactions: Avoid alcohol consumption while taking Veprate-ER-250 Tablet as it might cause increased dizziness and sleepiness. Alcohol intake might also provoke seizures.

Drug-Disease Interactions: Veprate-ER-250 Tablet may interact with disease conditions such as depression, liver disease, urea cycle disorders, suicidal tendency, HIV disease and thrombocytopenia (low levels of platelets).

Drug-Drug Interactions Checker List

  • ASPIRIN
  • PREGABALIN
  • TOPIRAMATE
  • PHENOBARBITAL
  • PRIMIDONE
  • PHENYTOIN
  • CARBAMAZEPINE
  • LAMOTRIGINE
  • FELBAMATE
  • ETHOSUXIMIDE
  • ZIDOVUDINE
  • DULOXETINE
  • ESCITALOPRAM
  • AMITRIPTYLINE
  • NORTRIPTYLINE
  • ARIPIPRAZOLE
  • LURASIDONE
  • QUETIAPINE
  • ALPRAZOLAM
  • RIFAMPICIN
  • WARFARIN
  • IMIPENEM
  • MEROPENEM
  • DIAZEPAM

Habit Forming

No

Diet & Lifestyle Advise

  • A ketogenic diet (low in carbohydrates and high in fats) is recommended for children with epilepsy. This diet helps in utilising fat instead of glucose for the generation of energy.

  • Atkins diet (high fay and controlled carbohydrates) is recommended for adolescents and adults.

  • Exercising regularly helps in maintaining weight and improving overall health. 

  • Rest well, get plenty of sleep.

  • Avoid smoking and alcohol consumption.

  • Meditation and yoga can help lower the stress, decrease pain sensitivity and improves coping skills.

  • Have a seizure response plan, help those around you know what to do.

  • Prepare your living area, small changes may reduce the risk of physical injury during a seizure.

  • Understand what triggers seizures and try reducing or avoiding them.

  • Please pay attention to overall health as it can help in reducing seizure activity.

  • Install an alarm or emergency device to get assistance during a seizure attack.

Special Advise

  • Regular monitoring of blood count and coagulation tests are advised while taking Veprate-ER-250 Tablet as it may cause thrombocytopenia (low platelet levels).

  • Veprate-ER-250 Tablet may cause liver toxicity, usually during the first 6months of treatment. Children below two years are at a higher risk. Regular monitoring of liver function tests before treatment and at frequent intervals is advised.

  • Veprate-ER-250 Tablet might alter thyroid function tests and urine ketone tests. Inform the person doing the tests that you are taking Veprate-ER-250 Tablet .

Disease/Condition Glossary

Epilepsy: Epilepsy is a sudden rush of electricity in the brain. It is a disorder of the nervous system which occurs due to disturbed nerve cell activity in the brain. In epilepsy, the brain's electrical rhythms become imbalanced, resulting in recurrent seizures. In patients with seizures, the typical brain electrical pattern is disrupted by sudden bursts of electrical impulses that affect an individual's consciousness, movements or sensations. Seizures are of two types: generalised and partial seizures. Generalised seizures affect the entire brain, whereas partial seizures affect only a part of the brain. Seizures can cause uncontrollable muscle twitches and spasms. Stronger seizures may cause people to become confused or unconscious. Possible causes include high fever, trauma, genetic disorder, brain injury or stroke.

Mood disorder: It is a mental health disorder which mainly affects a person's emotional state. A mood disorder is associated with episodes of mood swings ranging from manic highs to depressive lows.

Migraine: Migraine is a neurological condition which is characterized by intense headaches. Symptoms include nausea, vomiting, and sensitivity to light and sound.

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol while taking Veprate-ER-250 Tablet as it may cause increased dizziness.

bannner image

Pregnancy

Unsafe

Veprate-ER-250 Tablet belongs to pregnancy category D. Avoid taking Veprate-ER-250 Tablet if you are pregnant as it could lead to serious birth defects. Consult your doctor for further advice.

bannner image

Breast Feeding

Caution

Veprate-ER-250 Tablet may pass into breastmilk. Consult your doctor before taking Veprate-ER-250 Tablet if you are breastfeeding.

bannner image

Driving

Unsafe

Veprate-ER-250 Tablet causes dizziness and may affect thinking and motor skills. Do not drive or operate machinery.

bannner image

Liver

Caution

Veprate-ER-250 Tablet should not be used if you have liver problems or your family has a history of liver problems. Please consult your doctor if you have liver problems or any concerns regarding this.

bannner image

Kidney

Caution

Dose adjustment may be needed in patients with kidney impairment. Please consult your doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Caution

Veprate-ER-250 Tablet can be given to children if prescribed by the doctor. The doctor will adjust the dose depending on the child's body weight. Care should be taken in children below two years as they are at a higher risk of liver toxicity.

Country of origin

India
Other Info - VEP0028

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Veprate-ER-250 Tablet is used to treat epilepsy/seizures/fits. Additionally, it is also used to treat manic episodes associated with bipolar disorder and prevent migraines.
Veprate-ER-250 Tablet decreases the excessive and abnormal nerve activity in the brain. Thereby helps in controlling seizures.
Veprate-ER-250 Tablet helps to treat manic episodes associated with bipolar disorder by increasing the amount of a chemical substance called GABA, this helps in blocking the nerve transmission across the brain and provides a calming effect.
Veprate-ER-250 Tablet limits the transmission of nerve pain, thereby preventing migraine headaches. Migraine is a neurological condition which is characterized by intense headaches.
Veprate-ER-250 Tablet may interact with aspirin and cause abnormal side-effects. So, it is recommended to take any medication along with Veprate-ER-250 Tablet only after consulting a doctor.
Veprate-ER-250 Tablet may improve the symptoms of depression. However, do not use it without consulting a doctor as it may also cause mood disturbances and suicidal thoughts in some patients.
Do not discontinue Veprate-ER-250 Tablet without consulting your doctor. To treat your condition effectually, continue taking Veprate-ER-250 Tablet for as long as prescribed. Do not be reluctant to speak with your doctor if you feel any difficulty while taking Veprate-ER-250 Tablet ; your doctor will gradually reduce the dose to avoid worsening seizures.
Veprate-ER-250 Tablet may cause weight gain due to an increase in appetite. Maintain a healthy weight by following a healthy diet and exercising regularly.
Veprate-ER-250 Tablet may cause thrombocytopenia (low levels of platelets). This might increase the risk of bleeding and bruising. Be cautious while using sharp objects. Consult your doctor if you notice unexplained bleeding or bruising. Regular monitoring of blood count is advised while taking Veprate-ER-250 Tablet .
Topiramate (anticonvulsant) should not be taken along with Veprate-ER-250 Tablet as it may cause hyperammonemia (excess ammonia in the blood), hypothermia (low body temperature) and liver problems.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.